文献速递胸部技术与安全PETCT

18F-FAPI与18F-FDG PET/CT诊断原发性及转移性肺癌的比较

FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
PubMed 文献 · Radiology · 2023-01-01

该研究为前瞻性试验的二次分析,连续纳入单中心68例病理确诊肺癌患者,在间隔超过20小时且7天内行配对18F-FAPI与18F-FDG PET/CT。FAPI对转移性淋巴结和骨转移的肿瘤背景比高于FDG,对原发灶低于FDG;FAPI诊断敏感度、特异度、准确度和阴性预测值均高于FDG,阳性预测值无显著差异。

要点

  • FAPI对转移性淋巴结和骨转移的肿瘤背景比高于FDG,对原发灶低于FDG。
  • FAPI诊断敏感度99%高于FDG 87%,特异度93%高于FDG 79%。
  • FAPI准确度97%高于FDG 85%,阴性预测值97%高于FDG 70%。

核心结论

  • 18F-FAPI PET/CT在检测肺癌方面可能优于18F-FDG PET/CT。

研究设计与样本

  • 前瞻性试验的二次分析,单中心连续纳入68例病理确诊肺癌患者,于2020年12月至2022年4月前瞻性入组,行配对18F-FAPI与18F-FDG PET/CT检查,间隔超过20小时且7天内,以组织病理学和临床随访结果为最终诊断参考标准。

关键影像表现/征象

  • 原发肺癌FAPI肿瘤背景比25.3 ± 14.0低于FDG 32.1 ± 21.1(P < .001)。
  • 转移性淋巴结FAPI肿瘤背景比7.5 ± 6.6高于FDG 5.9 ± 8.6(P < .001)。
  • 骨转移FAPI肿瘤背景比8.6 ± 5.4高于FDG 4.3 ± 2.3(P < .001)。

诊断标准与关键数值

  • 全部548个病灶中,FAPI敏感度99%(392/397)高于FDG 87%(346/397),P < .001。
  • FAPI特异度93%(141/151)高于FDG 79%(120/151),P = .004。
  • FAPI准确度97%(533/548)高于FDG 85%(466/548),P < .001。
  • FAPI阴性预测值97%(141/146)高于FDG 70%(120/171),P < .001。
  • FAPI阳性预测值98%(392/402)与FDG 92%(346/377)无显著差异,P = .57。

临床应用与阅片要点

  • 作者结论认为18F-FAPI PET/CT在检测肺癌方面可能优于18F-FDG PET/CT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The radiotracer fluorine 18 (18F)-labeled fibroblast activation protein inhibitor (FAPI) has shown promise for visualizing several types of cancer, but the accuracy of 18F-FAPI compared with 18F-fluorodeoxyglucose (FDG) for the detection of lung cancer remains uncertain. Purpose To evaluate the effectiveness of 18F-FAPI-based PET/CT imaging for the diagnosis of primary and metastatic lung cancer lesions as compared with 18F-FDG PET/CT. Materials and Methods In this secondary analysis of a prospective trial, consecutively recruited patients from a single center with pathologically confirmed lung cancer were prospectively enrolled from December 2020 to April 2022 and underwent paired 18F-FAPI and 18F-FDG PET/CT examinations at intervals of more than 20 hours and within 7 days of each other. Histopathologic and clinical follow-up results were used as reference standards for final diagnoses. 18F-FAPI and 18F-FDG uptake were compared using the McNemar test or paired Student t test. Diagnostic accuracy was compared between the two techniques by using the McNemar χ2 test. Results Sixty-eight participants (median age, 63 years [IQR, 58-68 years; range, 42-79 years]; 46 male [68%]) were evaluated. Compared with the mean tumor-to-background ratio (TBR) for FDG uptake, TBR for FAPI uptake was lower in primary lung tumors (25.3 ± 14.0 [SD] vs 32.1 ± 21.1; P < .001) but higher in metastatic lymph nodes (7.5 ± 6.6 vs 5.9 ± 8.6; P < .001) and bone metastases (8.6 ± 5.4 vs 4.3 ± 2.3; P < .001). For diagnostic accuracy in a total of 548 lesions in 68 participants, compared with 18F-FDG PET/CT, 18F-FAPI PET/CT demonstrated a higher sensitivity (99% [392 of 397 lesions] vs 87% [346 of 397]; P < .001), specificity (93% [141 of 151 lesions] vs 79% [120 of 151]; P = .004), accuracy (97% [533 of 548 lesions] vs 85% [466 of 548]; P < .001), and negative predictive value (97% [141 of 146 lesions] vs 70% [120 of 171 lesions]; P < .001), but there was no evidence of a difference for positive predictive value (98% [392 of 402 lesions] vs 92% [346 of 377 lesions]; P = .57). Conclusion 18F-FAPI PET/CT may be superior to 18F-FDG PET/CT for detecting lung cancer. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Zukotynski and Gerbaudo in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Wei Y, Ma L, Li P, et al. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer. Radiology. 2023. PMID: 37552075. doi:10.1148/radiol.222785

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。